1-1 of 1
Keywords: Nadir prostate-specific antigen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Salvage External Beam Radiotherapy for Recurrent Prostate Adenocarcinoma after High-Intensity Focused Ultrasound as Primary Treatment

Available to Purchase
Subject Area:
Further Areas
Fernando Munoz, Alessia Guarneri, Angela Botticella, Pietro Gabriele, Francesco Moretto, Rocco Panaia, Andrea Ruggieri, Leonardo D'Urso, Giovanni Muto, Andrea Riccardo Filippi, Riccardo Ragona, Umberto Ricardi
Journal: Urologia Internationalis
Urol Int (2013) 90 (3): 288–293.
https://doi.org/10.1159/000345631
Published Online: 30 January 2013
... rate was 45.8%, with only few patients presenting grade III (8.3%) and grade IV (4.2%) toxicity. Late grade ≥III GU toxicity was registered in 16.7% of patients. The 3-year bDFS rate was 77.8%. Patients achieving a nadir prostate-specific antigen (nPSA) of ≤0.35 ng/ml after EBRT had significantly...
View article titled, Salvage External Beam Radiotherapy for Recurrent Prostate Adenocarcinoma after High-Intensity Focused Ultrasound as Primary Treatment
Open the PDF for Salvage External Beam Radiotherapy for Recurrent Prostate Adenocarcinoma after High-Intensity Focused Ultrasound as Primary Treatment in another window